TransCode Therapeutics Inc (RNAZ)
1.41
+0.08
(+6.02%)
USD |
NASDAQ |
May 10, 16:00
1.26
-0.15
(-10.64%)
After-Hours: 20:00
TransCode Therapeutics Price to Book Value: 4.991 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 4.991 |
| May 09, 2024 | 4.708 |
| May 08, 2024 | 3.611 |
| May 07, 2024 | 4.106 |
| May 06, 2024 | 2.884 |
| May 03, 2024 | 2.903 |
| May 02, 2024 | 2.503 |
| May 01, 2024 | 2.229 |
| April 30, 2024 | 2.149 |
| April 29, 2024 | 2.078 |
| April 26, 2024 | 1.946 |
| April 25, 2024 | 1.858 |
| April 24, 2024 | 1.557 |
| April 23, 2024 | 1.628 |
| April 22, 2024 | 1.625 |
| April 19, 2024 | 1.717 |
| April 18, 2024 | 1.777 |
| April 17, 2024 | 1.775 |
| April 16, 2024 | 1.788 |
| April 15, 2024 | 1.898 |
| April 12, 2024 | 2.199 |
| April 11, 2024 | 2.263 |
| April 10, 2024 | 2.267 |
| April 09, 2024 | 2.266 |
| April 08, 2024 | 2.318 |
| Date | Value |
|---|---|
| April 05, 2024 | 2.266 |
| April 04, 2024 | 2.407 |
| April 03, 2024 | 2.301 |
| April 02, 2024 | 2.414 |
| April 01, 2024 | 2.450 |
| March 28, 2024 | 2.418 |
| March 27, 2024 | 2.403 |
| March 26, 2024 | 2.336 |
| March 25, 2024 | 2.400 |
| March 22, 2024 | 2.358 |
| March 21, 2024 | 2.414 |
| March 20, 2024 | 2.478 |
| March 19, 2024 | 0.4442 |
| March 18, 2024 | 0.4355 |
| March 15, 2024 | 0.4449 |
| March 14, 2024 | 0.4442 |
| March 13, 2024 | 0.4211 |
| March 12, 2024 | 0.3831 |
| March 11, 2024 | 0.4113 |
| March 08, 2024 | 0.45 |
| March 07, 2024 | 0.47 |
| March 06, 2024 | 0.4507 |
| March 05, 2024 | 0.4424 |
| March 04, 2024 | 0.4507 |
| March 01, 2024 | 0.4636 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3117
Minimum
Jan 19 2024
4.991
Maximum
May 10 2024
1.522
Average
1.502
Median
Nov 18 2021
Price to Book Value Benchmarks
| Citius Pharmaceuticals Inc | 1.304 |
| NovaBay Pharmaceuticals Inc | 1.774 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7009 |
| Theriva Biologics Inc | 0.2004 |
Price to Book Value Related Metrics
| Price | 1.41 |
| Earnings Yield | -33.28K% |
| Market Cap | 8.189M |